Ariana Elizabeth Vargas Castillo, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thermogenesis | 6 | 2023 | 496 | 0.760 |
Why?
|
| Functional Food | 1 | 2021 | 20 | 0.740 |
Why?
|
| Adipose Tissue, White | 5 | 2023 | 370 | 0.700 |
Why?
|
| Genistein | 4 | 2023 | 87 | 0.570 |
Why?
|
| Adipose Tissue, Brown | 3 | 2023 | 776 | 0.530 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2021 | 595 | 0.310 |
Why?
|
| Mitochondria | 1 | 2021 | 3673 | 0.290 |
Why?
|
| Energy Metabolism | 5 | 2022 | 2892 | 0.220 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2021 | 22 | 0.180 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2021 | 126 | 0.170 |
Why?
|
| Soybean Proteins | 1 | 2020 | 55 | 0.170 |
Why?
|
| Angiotensin I | 1 | 2019 | 47 | 0.170 |
Why?
|
| Sirtuin 1 | 1 | 2021 | 245 | 0.170 |
Why?
|
| PPAR alpha | 1 | 2021 | 175 | 0.160 |
Why?
|
| Obesity | 3 | 2020 | 13076 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 798 | 0.130 |
Why?
|
| Anti-Obesity Agents | 1 | 2020 | 242 | 0.130 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 186 | 0.130 |
Why?
|
| Oxygen Consumption | 1 | 2021 | 1870 | 0.120 |
Why?
|
| Amino Acids | 1 | 2021 | 1709 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 1203 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 1242 | 0.100 |
Why?
|
| Cell Survival | 1 | 2021 | 5747 | 0.090 |
Why?
|
| Adipocytes | 1 | 2017 | 1194 | 0.090 |
Why?
|
| Metabolism | 2 | 2021 | 193 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 2531 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 4520 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5125 | 0.070 |
Why?
|
| Animals | 9 | 2023 | 168764 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3985 | 0.060 |
Why?
|
| Liver | 1 | 2021 | 7562 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 4958 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3819 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2019 | 11641 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 11888 | 0.050 |
Why?
|
| Response Elements | 1 | 2023 | 307 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 22332 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7478 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3785 | 0.050 |
Why?
|
| Mitoxantrone | 1 | 2021 | 148 | 0.040 |
Why?
|
| Daunorubicin | 1 | 2021 | 157 | 0.040 |
Why?
|
| Anorexia | 1 | 2021 | 153 | 0.040 |
Why?
|
| Neomycin | 1 | 2020 | 94 | 0.040 |
Why?
|
| Indomethacin | 1 | 2021 | 322 | 0.040 |
Why?
|
| Ampicillin | 1 | 2020 | 138 | 0.040 |
Why?
|
| Caseins | 1 | 2020 | 105 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2019 | 70 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 100 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2021 | 379 | 0.040 |
Why?
|
| Mice | 6 | 2023 | 81819 | 0.040 |
Why?
|
| Diet | 1 | 2017 | 8086 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2019 | 197 | 0.040 |
Why?
|
| Indazoles | 1 | 2021 | 303 | 0.040 |
Why?
|
| Endotoxemia | 1 | 2020 | 198 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2021 | 566 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 502 | 0.040 |
Why?
|
| 3T3-L1 Cells | 1 | 2019 | 206 | 0.040 |
Why?
|
| Glucose | 2 | 2022 | 4335 | 0.040 |
Why?
|
| Vincristine | 1 | 2021 | 1039 | 0.040 |
Why?
|
| Nausea | 1 | 2021 | 680 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 657 | 0.040 |
Why?
|
| Vomiting | 1 | 2021 | 647 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 482 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2023 | 1744 | 0.030 |
Why?
|
| Zinc | 1 | 2021 | 675 | 0.030 |
Why?
|
| Glycolysis | 1 | 2021 | 838 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2020 | 1884 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 622 | 0.030 |
Why?
|
| Rats | 2 | 2023 | 23707 | 0.030 |
Why?
|
| Fibronectins | 1 | 2019 | 719 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14448 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2021 | 1069 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 1314 | 0.030 |
Why?
|
| Diarrhea | 1 | 2021 | 1316 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2021 | 2927 | 0.030 |
Why?
|
| Vitamins | 1 | 2021 | 1630 | 0.030 |
Why?
|
| Humans | 7 | 2021 | 765968 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2020 | 1806 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4260 | 0.020 |
Why?
|
| Body Weight | 1 | 2022 | 4622 | 0.020 |
Why?
|
| Inflammation | 2 | 2021 | 10850 | 0.020 |
Why?
|
| Body Composition | 1 | 2020 | 2439 | 0.020 |
Why?
|
| Weight Gain | 1 | 2020 | 2355 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3141 | 0.020 |
Why?
|
| Overweight | 1 | 2021 | 2444 | 0.020 |
Why?
|
| Protein Binding | 1 | 2021 | 9296 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2020 | 3312 | 0.020 |
Why?
|
| Vitamin D | 1 | 2021 | 3272 | 0.020 |
Why?
|
| Insulin | 1 | 2021 | 6599 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12437 | 0.020 |
Why?
|
| Male | 5 | 2021 | 363698 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8611 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 17075 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2019 | 18973 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11868 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59889 | 0.010 |
Why?
|
| Child | 1 | 2021 | 80564 | 0.010 |
Why?
|
| Female | 2 | 2021 | 396112 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 223009 | 0.000 |
Why?
|
| Adult | 1 | 2019 | 223044 | 0.000 |
Why?
|